
About Ameliorate Biotech
Ameliorate Biotech is a Healthcare company based in Bengaluru (India) founded in 2015 by Binita Shrivastava Tunga and Rashbehari Tunga. Developer of recombinant therapeutic proteins and diagnostic kits. Ameliorate Biotech has raised $549.34 thousand across 6 funding rounds from investors including LetsVenture, Padup Ventures and DERBI Foundation. Ameliorate Biotech was last valued at $1.65 million in March 2021. Its chief executive, as recorded, is Rashbehari Tunga. Its Indian entity Ameliorate Biotech Private Limited reported revenue of βΉ22.3 Lakh. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
Ameliorate Biotech was founded in 2015 in Bengaluru, India, within the biotechnology sector. Recombinant therapeutic proteins and diagnostic kits are produced using an antibiotic-free process. Biosimilar products are being developed to address treatments in oncology, autoimmune diseases, ophthalmology, and nephrology. Operations focus on advancing therapeutic solutions through recombinant technology.
- Headquarters Bengaluru, India
- Founders Binita Shrivastava Tunga, Rashbehari Tunga
- Stage Minicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website amelioratebiotech.com
- Legal Name Ameliorate Biotech Private Limited
- Date of Incorporation 20 Oct, 2015
- Jurisdiction Off Kanakapura Road Tataguni, Karnataka, India
- Annual Revenue₹22.3 Lakh
FY 2025 · -29% YoY
- Net Loss-₹61.3 Lakh
FY 2025 · -275% margin
- EBITDA-₹53.7 Lakh
FY 2025 · -241% margin
- Total Equity Funding$549.34K (USD)
in 6 rounds
- Latest Funding Round$128.28K (USD), Seed
Mar 2021
- InvestorsLetsVenture
& 10 more
Associated legal entities of Ameliorate Biotech
Ameliorate Biotech operates through Ameliorate Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ameliorate Biotech Private Limited CIN U74900KA2015PTC083551 | Active | 20 Oct 2015 | Bangalore, Karnataka | ₹0.2 Cr | 2 | View details |
Funding Insights of Ameliorate Biotech
Ameliorate Biotech has successfully raised a total of $549.34K across 6 strategic funding rounds. The most recent funding activity was a Seed round of $128.28 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $549,337
- Total Rounds 6
- Last Round Seed β $128,282
- Investors Count 11
All 6 funding rounds of Ameliorate Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $128,282 | Seed | $1.65M | β | β |
| Sep 2020 | $139,991 | Seed | $1.38M | β | β |
| Jun 2020 | $265,362 | Seed | $β’β’β’β’β’ | LetsVenture | |
| Jan 2020 | Angel Round | β | β | β | |
| May 2019 | $15,703 | Angel Round | $β’β’β’β’β’ | Gururaj Narayan | |
| Aug 2017 | Grant | β | β |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2021 | $1.65M | β’β’β’β’β’β’β’β’ |
| Sep 2020 | $1.38M | β’β’β’β’β’β’β’β’ |
| Jun 2020 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
| May 2019 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of Ameliorate Biotech
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $1.65M (Mar 2021). 11 investors in total: 8 institutional and 3 angel.
Investors in Ameliorate Biotech
Ameliorate Biotech has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LetsVenture, Padup Ventures and DERBI Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Empowering tech startups through funding and support services. | 2015 | padup.in | Gurugram, India | |
Support for innovation and entrepreneurship through incubation programs in Bangalore. | 2015 | derbifoundation.com | Bengaluru, India | |
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay. | sineiitb.org | Mumbai, India | ||
No specific information about Vinners is provided. | vinners.net | |||
Online platform that connects startup founders with accredited investors, enabling early-stage fundraising and investment opportunities for private market growth | 2013 | letsventure.com | Bengaluru, India | |
Support is extended to individuals and families through community initiatives. | siliconvalleycf.org | Mountain View, United States | ||
Support is extended to innovators and entrepreneurs by the foundation. | ief-fie.ca | Ottawa, Canada | ||
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India | |
GN Gururaj Narayan | unknown_f1ee1dccb57044518 | |||
AS Atul Srivastava | Angel investor and tech entrepreneur, co-founder of Gaana, active in Indian startups | unknown_6d751200cbe04b889 |
Investor details for Ameliorate Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ameliorate Biotech Private Limited (Ameliorate Biotech)
Ameliorate Biotech Private Limited is the primary company behind Ameliorate Biotech. The board of Ameliorate Biotech Private Limited currently have 2 directors; the longest-serving is Rashbehari Tunga, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rashbehari Tunga DIN 07321427 | Director | 20 Oct 2015 | 11 yrs | Ameliorate Biotech Private Limited |
| Binita Shrivastava Tunga DIN 07318643 | Director | 20 Oct 2015 | 11 yrs | Ameliorate Biotech Private Limited |
People of Ameliorate Biotech
2 people are tracked at Ameliorate Biotech (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CTO | Leadership | |
| Co-Founder & CEO | Leadership |
Complete people profiles for Ameliorate Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Ameliorate Biotech
Figures of Ameliorate Biotech Private Limited, the primary company behind Ameliorate Biotech, for FY 2025. Revenue was ₹22.3 Lakh (-29% year on year). Net loss was -₹61.3 Lakh (-275% margin). EBITDA was -₹53.7 Lakh (-241% margin). Revenue has grown at a compounded annual rate of +18% over five years.
- ₹22.3 LakhRevenue · FY 2025 · -29% YoY
- -₹61.3 LakhNet loss · -275% margin
- -₹53.7 LakhEBITDA · -241% margin
- ₹8.6 LakhPaid-up capital
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ameliorate Biotech Private Limited are on its company page.
Detailed financial statements for Ameliorate Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ameliorate Biotech
4 dated milestones of Ameliorate Biotech across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Ameliorate Biotech is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $128K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ameliorate Biotech
Complete news archive for Ameliorate Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ameliorate Biotech
Ameliorate Biotech was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Ameliorate Biotech is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rashbehari Tunga is the CEO of Ameliorate Biotech, as recorded in our data. They have also founded this company.
Ameliorate Biotech is a funded company, having raised a total of $549.34K across 6 funding rounds to date.
The primary company behind Ameliorate Biotech, Ameliorate Biotech Private Limited, reported revenue of βΉ22.3 Lakh for FY 2025, down 29% year on year.
Ameliorate Biotech was founded in 2015 in Bengaluru, India, within the biotechnology sector. Recombinant therapeutic proteins and diagnostic kits are produced using an antibiotic-free process. Biosimilar products are being developed to address treatments in oncology, autoimmune diseases, ophthalmology, and nephrology. Operations focus on advancing therapeutic solutions through recombinant technology.
Ameliorate Biotech has 11 investors. Key investors include LetsVenture, Padup Ventures, DERBI Foundation, Startup Karnataka, and SINE.
The valuation of Ameliorate Biotech is $1.65M as of Mar 2021.
Ameliorate Biotech operates through Ameliorate Biotech Private Limited.
The legal entities of Ameliorate Biotech currently have 2 directors, including Rashbehari Tunga, Binita Shrivastava Tunga.
